EHC - ERN-EuroBloodNet Topic on Focus on Von Willebrand Disease: Treating VWD-What are the options?

Webinar #6 Topic on Focus on Von Willebrand Disease (VWD): Treating VWD - What are the options?
Speakers: Prof Sophie Susan (CHU de Lille, France) and Cathy Verbraeken (Dutch Haemophilia Society, EHC VWD Committee)
"Topic on Focus: von Willebrand Disease (VWD) for patient organisations and healthcare professionals" has been coordinated by the EHC, represented by the EHC VWD Committee and patient representatives, and the ERN-EuroBloodNet. This educational programme is created in partnership with EURORDIS-Rare Diseases Europe and supported by members of the scientific committee: Prof Sophie Susen (CHU de Lille, France), Prof Jeroen Eikenboom (Leiden University Medical Center, The Netherlands), Prof Flora Peyvandi (Foundation IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy).
This programme aims to distinguish VWD from haemophilia and focuses on the particularities of this bleeding disorder. The programme also aims to discuss very topical areas related to VWD among patients and healthcare professionals to give visibility to the challenges of those living with this rare disease, including quality of life, access to treatments and care, medical services available in Europe, diagnosis and treatments options, and the overall patient journey through life. A further objective of this programme is to disseminate up-to-date knowledge among interested haematologists, gynaecologists, internists, paediatricians, nurses or other healthcare providers and patient organisations in the field of VWD. Ultimately, this approach aims to support better patient care.
Each session is moderated by a duo of an expert physician or/and nurse, a psychologist and a patient representative, who host the session together. The healthcare professional introduces the topic and shares clinical knowledge, and the patient representative ensures that the information provided is contextualised and accessible to patients and their families. The programme further also highlights the key crucial concepts, encouraging a dialogue between patients to the experts and seeking clarification of these for the webinar audience.
Organisers:
ERN-EuroBloodNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States and covers Rare Hematological Diseases (RHD). Please visit EuroBloodNet’s website to explore different initiatives we work on and how we can support patients and health professionals in the field of (RHD): eurobloodnet.eu/
The content of the ERN-EuroBloodNet’s TH-cam channel is carried out within the framework of the European Reference Network on Rare Haematological Diseases (ERN-EuroBloodNet)-Project ID No 101085717. ERN-EuroBloodNet is partly co-funded by the European Union within the framework of the Fourth EU Health Programme. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
The European Haemophilia Consortium (EHC) is an international non-profit organisation representing 48 national patient organisations for people with rare bleeding disorders located in the World Health Organisation (WHO) European region, including 27 Member States of the European Union and most Member States of the Council of Europe.
The EHC represents approximately 120,000 people diagnosed with rare bleeding conditions such as haemophilia, von Willebrand Disease (VWD), and other extremely rare bleeding disorders across Europe. However, experts estimate that many more live with an undiagnosed rare bleeding disorder. Please visit the EHC Community website to learn more about the EHC’s work focused on VWD: community.ehc....